AUTL - Autolus Therapeutics GAAP EPS of -$0.47 in-line revenue of $2.37M beats by $2.23M
- Autolus Therapeutics press release ( NASDAQ: AUTL ): Q3 GAAP EPS of -$0.47 in-line.
- Revenue of $2.37M (+887.5% Y/Y) beats by $2.23M .
- Net loss attributable to ordinary shareholders was $42.8 million for the three months ended September 30.
For further details see:
Autolus Therapeutics GAAP EPS of -$0.47 in-line, revenue of $2.37M beats by $2.23M